Hirata, F., Ishiyama, K., Tanaka, Y., Kobayashi, T., Hashimoto, M., Saeki, Y., . . . Ohdan, H. (2018). Effect of bevacizumab plus XELOX (CapeOX) chemotherapy on liver natural killer cell activity in colorectal cancer with resectable liver metastasis. Ann Gastroenterol Surg.
Styl ChicagoHirata, Fumihiro, et al. "Effect of Bevacizumab Plus XELOX (CapeOX) Chemotherapy On Liver Natural Killer Cell Activity in Colorectal Cancer With Resectable Liver Metastasis." Ann Gastroenterol Surg 2018.
Citace podle MLAHirata, Fumihiro, et al. "Effect of Bevacizumab Plus XELOX (CapeOX) Chemotherapy On Liver Natural Killer Cell Activity in Colorectal Cancer With Resectable Liver Metastasis." Ann Gastroenterol Surg 2018.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..